Papers

7

Total Citations

102

H-Index

5

About

Teng Mao is a leading thoracic surgeon and researcher at Shanghai Chest Hospital, whose work centers on advancing surgical techniques for esophageal squamous cell carcinoma (ESCC). His primary research areas include robot-assisted esophagectomy (RAE) and minimally invasive esophagectomy (MIE), with a focus on improving patient outcomes through comparative effectiveness studies. Mao’s major contribution is his pioneering role in the RAMIE trial, a multicenter prospective randomized controlled trial comparing RAE to conventional MIE for resectable ESCC—a study that has garnered 61 citations and is shaping surgical standards. He has also reported on one of the largest single-center RAE series, involving 249 patients, demonstrating the feasibility and safety of robotic approaches. Beyond individual studies, Mao has authored the annual reports of thoracic surgery services at Shanghai Chest Hospital since 2016, providing critical real-world data on esophageal cancer surgical treatment and survival outcomes. These reports, with cumulative citations, establish him as a key figure in evidence-based thoracic surgery. His work is essential reading for students and researchers interested in robotic surgery, esophageal oncology, and high-volume center outcomes.

Research Focus

Key Achievements

5
H-Index
7
Papers
102
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy)
61 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 54
🏛 Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago